xFeed Blog Study: Speaking Two Languages Delays Onset of Dementia

Podcast: Discussing the Ceregene Clinical Trial Results

Saturday, 4 May 2013

In this podcast, MJFF Contributing Editor Dave Iverson reports on recent disappointing clinical trial results of San Diego-based biotech Ceregene’s trophic factor therapy CERE-120. For perspective on what the results mean for CERE-120 and trophic factors moving forward, Iverson speaks withWilliam…

Podcast: Limiting On-Off Periods in Parkinson’s Medications

Monday, 12 March 2012

While levodopa is the gold standard therapy for Parkinson’s disease (PD), current delivery methods have their limitations. Many patients who take it experience “off” periods, when the medication’s effects wear off before they are ready to take their next dose, leaving…